ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
Merck and Pfizer Announce FDA and EMA Filing Acceptances of Three Marketing Applications for Ertugli
March 07, 2017Merck and Pfizer announced that the U.S. Food and Drug Administration (FDA) has accepted for review three New Drug Applications (NDAs) for medicines containing ertugliflozin, an investigational SGLT2 inhibitor in development to help improve glycemic contr
Pharma Sources Insight January 2025
